5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | BUY | NEUTRAL | NEUTRAL | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.34▼ | 2.32▼ | 2.32▼ | 2.22▲ | 2.29▼ |
MA10 | 2.32▼ | 2.31▼ | 2.32▼ | 2.22▲ | 2.31▼ |
MA20 | 2.31▼ | 2.28▲ | 2.25▲ | 2.31▼ | 1.98▲ |
MA50 | 2.25▲ | 2.22▲ | 2.22▲ | 2.29▼ | 1.78▲ |
MA100 | 2.22▲ | 2.26▲ | 2.32▼ | 1.88▲ | 2.30▼ |
MA200 | 2.32▼ | 2.41▼ | 2.37▼ | 1.69▲ | 1.82▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.002▼ | 0.002▲ | 0.008▲ | -0.012▼ | 0.026▲ |
RSI | 49.329▼ | 53.511▲ | 54.249▲ | 49.431▼ | 57.667▲ |
STOCH | 65.873 | 53.512 | 65.327 | 37.166 | 51.039 |
WILL %R | -93.333▼ | -41.176 | -41.176 | -47.790 | -39.706 |
CCI | -62.275 | -27.559 | 12.083 | 64.592 | 33.056 |
Tuesday, July 22, 2025 04:03 AM
On July 1, Lake Street Capital Markets initiated coverage on Aytu Biosciences (NASDAQ:AYTU) with a Buy rating and an $8.00 price target, citing strong prospects following its acquisition of EXXUA.
|
Saturday, July 05, 2025 05:00 PM
Aytu BioPharma has a twelve month low of $0.95 and a twelve month high of $2.91. Aytu BioPharma (NASDAQ:AYTU – Get Free Report) last posted its quarterly earnings results on Wednesday, May 14th.
|
Wednesday, June 25, 2025 05:00 AM
DENVER, CO/ ACCESS Newswire/ June 25, 2025/ Aytu BioPharma, Inc., a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
26/08/25 | 2.31 | 2.4067 | 2.25 | 2.28 | 80,602 |
25/08/25 | 2.25 | 2.40 | 2.21 | 2.295 | 126,433 |
22/08/25 | 2.22 | 2.28 | 2.174 | 2.20 | 94,665 |
21/08/25 | 2.15 | 2.19 | 2.1052 | 2.18 | 67,954 |
20/08/25 | 2.20 | 2.20 | 2.11 | 2.15 | 98,624 |
19/08/25 | 2.21 | 2.25 | 2.16 | 2.20 | 35,375 |
18/08/25 | 2.18 | 2.28 | 2.16 | 2.20 | 127,899 |
15/08/25 | 2.19 | 2.24 | 2.18 | 2.21 | 65,159 |
14/08/25 | 2.20 | 2.23 | 2.15 | 2.19 | 121,079 |
13/08/25 | 2.28 | 2.3399 | 2.25 | 2.29 | 103,462 |
|
|
||||
|
|
||||
|
|